50 "

: Abbosynagis 50 Mg. ?  »
|
-

I.M

Powder For Solution For Injection

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

119 63 30030 00

Abbvie S.r.l., Italy

07/2010 - 07/2020

.
, .
.
/
Palivizumab 50 MG
Vial glass type i 1 x 4 ML 48

*

*

 

.

? !
 »
 
" !
 

...
 »
190
-